Octa(OtBu)-Glu-OtBu represents a fully protected glutamate polymer useful for controlled deprotection studies and backbone extension. Its steric bulk influences solubility and resin-bound coupling. Researchers evaluate its handling characteristics for synthetic optimization. Uses include peptide-material construction, solid-phase method development, and modular sequence design.
CAT No: R2535
CAS No:1188328-39-3
Synonyms/Alias:Octa(OtBu)-Glu-OtBu;1188328-39-3;(S)-5-(tert-butoxy)-4-(18-(tert-butoxy)-18-oxooctadecanamido)-5-oxopentanoic acid;MFCD34566912;SCHEMBL12674184;XKQUPBJUBPAMDO-VWLOTQADSA-N;285496VG3C;(4S)-5-tert-butoxy-4-[(18-tert-butoxy-18-oxo-octadecanoyl)amino]-5-oxo-pentanoic acid;L-Glutamic acid, N-[18-(1,1-dimethylethoxy)-1,18-dioxooctadecyl]-, 1-(1,1-dimethylethyl) ester;CS-0142642;G18726;4-Boc-4-(17-Boc-heptadecanamido)butanoic Acid, (S)-;(4S)-5-t-Butoxy-4-[(18-tert-butoxy-18-oxo-octadecanoyl)amino]-5-oxo-pentanoic acid;1-(1,1-Dimethylethyl) hydrogen N-[18-(1,1-dimethylethoxy)-1,18-dioxooctadecyl]-L-glutamate;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.